The Expression and Biological Significance of PD-L1 on Lung Cancer Cell Lines
Background and objective Tumor-associated PD-L1 expression was recently shown to promote T-cell apoptosis and proposed as a potential mechanism of immune evasion by tumors. On the basis of the ability of tumor-associated PD-L1 to mediate activated T-cell death, it is likely that manipulation of the...
Main Authors: | Cheng CHEN, Chuanyong MU, Qiuxia QU, Yibei ZHU, Jing SUN, Xueguang ZHANG, Jian’an HUANG |
---|---|
Format: | Article |
Language: | zho |
Published: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2009-08-01
|
Series: | Chinese Journal of Lung Cancer |
Subjects: | |
Online Access: | http://www.lungca.org/index.php?journal=01&page=article&op=viewFile&path[]=10.3779%2Fj.issn.1009-3419.2009.08.005&path[]=983 |
Similar Items
-
Clinical Analysis of Docetaxel Combined with PD-1/PD-L1 Inhibitor in Second-line Treatment of Advanced Non-small Cell Lung Cancer
by: Qing CHEN, et al.
Published: (2021-09-01) -
Predictive Markers for Treating Efficacy of PD-1/PD-L1 Inhibitors in Patients with Lung Cancer: A Review of the 18th World Conference on Lung Cancer
by: Guanxuan CHEN, et al.
Published: (2018-09-01) -
Clinical Research Progress of Anti PD-1/PD-L1 Monoclonal Antibody in the Treatment of Lung Cancer
by: Zhiyu HUANG, et al.
Published: (2015-11-01) -
Progress of Immunotherapy Mechanisms and Current Evidence of PD-1/PD-L1
Checkpoint Inhibitors for Non-small Cell Lung Cancer with Brain Metastasis
by: Jiamin SHENG, et al.
Published: (2020-11-01) -
Progress in Clinical Researches of PD-1/PD-L1 Checkpoint Inhibitor for
Non-small Cell Lung Cancer
by: Sixuan WU, et al.
Published: (2019-07-01)